William Brian Dalton

13PUBLICATIONS
59CO-AUTHORS
Molecular targetsHaematological tumoursCancer cell biologyMedical virologyMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Oct 23, 2026
Serine auxotrophy is a targetable vulnerability driven by PSAT1 suppression in AML.

|Oct 07, 2026
Outcome heterogeneity in CALR-mutated myeloproliferative neoplasms.

|Aug 03, 2026
Targeting EZH2 oncogenic splicing: decoding the regulatory network and antisense correction.

|Feb 15, 2026
Chemotherapy regimens with second generation tyrosine kinase inhibitors for BCR-ABL B-cell acute lymphoblastic leukemia: comparative outcomes and role of allogeneic hematopoietic cell transplantation.

John Preston Claiborne, Hua-Ling Tsai, Gabriel Ghiaur

|Oct 07, 2025
Distinct and convergent effects of SF3B1 mutations in human breast cancer.

Riley E Bergman, Christin I Keeton, Irika R Sinha

|Jun 04, 2025
Serine auxotrophy is a targetable vulnerability driven by PSAT1 suppression in AML.

Ilias Sinanidis, Panagiotis Tsakiroglou, Benjamin Dubner

Pageof 3

Frequent Collaborators

5 joint publications

Tania Jain

4 joint publications

Gabriel Ghiaur

4 joint publications

Jonathan Webster

3 joint publications

Theodoros Karantanos